August 27, 2014: Among the 11 stocks making new 52-week lows today were the following three firms:
Ampio Pharmaceuticals Inc. (NYSEMKT: AMPE) dropped another 4.5% on Wednesday to post a new 52-week low of $4.65. The company’s shares dropped 24% last Thursday following a delay in a STEP study for its osteoarthritis drug, and the slide hasn’t stopped. Share volume is about 40% above the daily average of around 850,000. The stock’s 52-week high is $10.86.
Eclipse Resources Corp. (NYSE: ECR) slipped another 1.2% today, adding to a decline of about 3% on Monday and 2.4% yesterday to post another new 52-week low of $17.26 compared with the stock’s 52-week high of $27.18. The high was posted on Eclipse’s IPO date and the stock is down more than 32% since the June 20th IPO. Volume is again about half the daily average of around 1.4 million shares traded.
Titan Machinery Inc. (NASDAQ: TITN) dropped about 8.3% today to post a new 52-week low of $12.33. Volume is about 4-times the daily average of around 160,000 shares. The company had no news today other than announcing its second-quarter conference call for September 9th.. The company’s 52-week high is $20.40.
ALSO READ: Companies That Control the World’s Food
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.